Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma

Journal of Nuclear Medicine

Volumn 37, Issue 11, 1996, Pages 1860-1864

  M'Kacher, R ^b   Legal, J D ^b   Schlumberger, M ^b   Voisin, P ^b   Aubert, B ^b   Gaillard, N ^b   Parmentier, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

dosimetry; iodine 131; thyroid cancer

Indexed keywords

COBALT 60; IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CHROMOSOME 4; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DICENTRIC CHROMOSOME; DOSIMETRY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; THYROID CARCINOMA;

CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 4; COBALT RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; IODINE RADIOISOTOPES; LYMPHOCYTES; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; THYROID NEOPLASMS;

EID: 0029861188     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Annals of the ICRP. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53, 1987.
2. MIRD primer for absorbed dose calculations. Society of Nuclear Medicine 1988: New York, NY.
3. Izembart M, Chavaudra J, Aubert B, Vallée G. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. Eur J Nucl Med 1992;19:243-247.
4. Boyd E, Buchanan WW, Lennox B. Damage to chromosomes by therapeutic doses of radioiodine. Lancet 1961;i:977-978.
5. Baugnet-Mahieu L, Lemaire M, Léonard ED, Léonard A, Gerber GB. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 1994;140:429-431.
6. 131I. Cancer Lett 1995;91:199-204.
7. Lloyd DC, Purrott RJ, Dolphin GW, Horton PW, Halnan KE, Scott JS, Mair G. A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma. Int J Radiat Biol 1976;30:473-485.
8. Livingston GK, Foster AR, Elson HR. Effect of in vitro exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes. J Toxicol Environ Health 1993;40:367-375.
9. Léonard A, Baltus I, Léonard ED, Gerber GB, Richard F, Wambersie A. Dose-effect relationship for in vivo and in vitro induction of dicentric aberrations in blood lymphocytes of children. Radiat Res 1995;141:95-98.
10. Lloyd DC, Purrott RJ, Reeder EJ. The incidence of unstable chromosome aberrations in peripheral blood lymphocytes from unirradiated and occupationally exposed people. Mutat Res 1980;72:523-532.
11. Pinkel D, Straume T, Gray J. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-2938.
12. Doloy MT. Dosimetry based on scoring of chromosomal aberrations in blood lymphocytes. Radioprotection 1994;26:171-184.
13. Lucas JN, Tenjin T, Straume T, Pinkel D, Moore H D, Litt M, Gray JW. Rapid human chromosome aberration analysis using fluorescence in situ hybridization. Int J Radiat Biol 1989;56:35-44.
14. Lucas JN, Poggensee M, Straume T. The persistence of chromosome translocations in a radiation worker accidentally exposed to tritium. Cytogenet Cell Genet 1992;60: 255-256.
15. Lloyd DC, Edwards AA, Prosser JS. Chromosomal aberrations induced in human lymphocytes by in vitro acute x and gamma radiation. Radiat Prot Dos 1986;15:83-88.
16. Natarajan AT, Vyas RC, Darroudi F, Vermeulen S. Frequencies of x-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries. Int J Radiat Biol 1992;61: 199-203.
17. Tucker JD, Ramsey MJ, Lee DA, Minkler JL. Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int J Radiat Biol 1993;64:27-37.
18. Schmid E, Zitzelsberger H, Braselmann H, Gray JW, Bauchinger M. Radiation-induced chromosome aberrations analyzed by fluoresence in situ hybridization with a triple combination of composite whole chromosome-specific DNA probes. Int J Radiat Biol 1992;62:673-678.
19. Agence Internationale de l'Energie Atomique (AIEA). Biological dosimetry:chromosomal aberration analysis for dose assessment. Technical Report Series No. 260 Vienna AIEA; 1986.
20. Cremer T, Popp S, Emmerich P, Lichter P, Cremer C. Rapid metaphase and interphase detection of radiation-induced chromosome aberrations in human lymphocytes by chromosomal suppression in situ hybridization. Cytometry 1990;11:110-118.
21. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy in 394 patients with lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:538-605.
22. Edmonds CJ, Smith T. The long-term hazards of treatment of thyroid cancer with radioiodine. Br J Radiol 1986;59:45-51.
23. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995;36:21-27.